Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Movement-related beta and gamma oscillations indicate parallels and disparities between Alzheimer's disease and HIV-associated neurocognitive disorder.
Meehan CE, Schantell M, Springer SD, Wiesman AI, Wolfson SL, O'Neill J, Murman DL, Bares SH, May PE, Johnson CM, Wilson TW. Meehan CE, et al. Among authors: murman dl. Neurobiol Dis. 2023 Oct 1;186:106283. doi: 10.1016/j.nbd.2023.106283. Epub 2023 Sep 6. Neurobiol Dis. 2023. PMID: 37683957 Free PMC article.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Piecing it together: atrophy profiles of hippocampal subfields relate to cognitive impairment along the Alzheimer's disease spectrum.
Christopher-Hayes NJ, Embury CM, Wiesman AI, May PE, Schantell M, Johnson CM, Wolfson SL, Murman DL, Wilson TW. Christopher-Hayes NJ, et al. Among authors: murman dl. Front Aging Neurosci. 2023 Oct 31;15:1212197. doi: 10.3389/fnagi.2023.1212197. eCollection 2023. Front Aging Neurosci. 2023. PMID: 38020776 Free PMC article.
Trial of Solanezumab in Preclinical Alzheimer's Disease.
Sperling RA, Donohue MC, Raman R, Rafii MS, Johnson K, Masters CL, van Dyck CH, Iwatsubo T, Marshall GA, Yaari R, Mancini M, Holdridge KC, Case M, Sims JR, Aisen PS; A4 Study Team. Sperling RA, et al. N Engl J Med. 2023 Sep 21;389(12):1096-1107. doi: 10.1056/NEJMoa2305032. Epub 2023 Jul 17. N Engl J Med. 2023. PMID: 37458272 Free PMC article. Clinical Trial.
AI-based differential diagnosis of dementia etiologies on multimodal data.
Xue C, Kowshik SS, Lteif D, Puducheri S, Jasodanand VH, Zhou OT, Walia AS, Guney OB, Zhang JD, Pham ST, Kaliaev A, Andreu-Arasa VC, Dwyer BC, Farris CW, Hao H, Kedar S, Mian AZ, Murman DL, O'Shea SA, Paul AB, Rohatgi S, Saint-Hilaire MH, Sartor EA, Setty BN, Small JE, Swaminathan A, Taraschenko O, Yuan J, Zhou Y, Zhu S, Karjadi C, Ang TFA, Bargal SA, Plummer BA, Poston KL, Ahangaran M, Au R, Kolachalama VB. Xue C, et al. Among authors: murman dl. medRxiv [Preprint]. 2024 Mar 26:2024.02.08.24302531. doi: 10.1101/2024.02.08.24302531. medRxiv. 2024. PMID: 38585870 Free PMC article. Preprint.
Altered visual entrainment in patients with Alzheimer's disease: magnetoencephalography evidence.
Springer SD, Wiesman AI, May PE, Schantell M, Johnson HJ, Willett MP, Castelblanco CA, Eastman JA, Christopher-Hayes NJ, Wolfson SL, Johnson CM, Murman DL, Wilson TW. Springer SD, et al. Among authors: murman dl. Brain Commun. 2022 Aug 1;4(4):fcac198. doi: 10.1093/braincomms/fcac198. eCollection 2022. Brain Commun. 2022. PMID: 35974799 Free PMC article.
47 results